Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients

被引:72
作者
Majima, T
Komatsu, Y
Yamada, T
Koike, Y
Shigemoto, M
Takagi, C
Hatanaka, I
Nakao, K
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068507, Japan
[2] Rakuwakai Otowa Hosp, Dept Endocrinol & Metab, Kyoto, Japan
关键词
bone mineral density; distal radius; insulin levels; type 2 diabetes mellitus;
D O I
10.1007/s00198-004-1786-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study is to assess the association between type 2 diabetes and bone mineral density. This study included 145 Japanese patients (64 men and 81 women) with type 2 diabetes and 95 non-diabetic control subjects (41 men and 54 women) of similar age. We measured bone mineral density (BMD) at the sites with different cortical/cancellous bone ratio (lumbar spine, femoral neck, and distal radius) using dual-energy X-ray absorptiometry. BMD and Z score at the distal radius were significantly lower in type 2 diabetic patients than those in control subjects, and in type 2 diabetic patients, the Z score at the distal radius was lower than that at their own lumbar spine and femoral neck. In type 2 diabetic patients, negative correlation between BMD and the mean HbA1c during the previous 2 years was found significantly at the distal radius in both genders and at the femoral neck in women. These results indicate the selective cortical bone loss in type 2 diabetes and suggest the importance of also determining BMD at the radius and keeping good metabolic control to prevent bone loss in type 2 diabetic patients.
引用
收藏
页码:907 / 913
页数:7
相关论文
共 37 条
[1]  
Akanuma Y, 1996, DIABETIC MED, V13, pS11
[2]   Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements [J].
Akin, O ;
Göl, K ;
Aktürk, M ;
Erkaya, S .
GYNECOLOGICAL ENDOCRINOLOGY, 2003, 17 (01) :19-29
[3]   Androgen supplementation in eugonadal men with osteoporosis - Effects of 6 months of treatment on bone mineral density and cardiovascular risk factors [J].
Anderson, FH ;
Francis, RM ;
Faulkner, K .
BONE, 1996, 18 (02) :171-177
[4]   Glucose-induced inhibition of in vitro bone mineralization [J].
Balint, E ;
Szabo, P ;
Marshall, CF ;
Sprague, SM .
BONE, 2001, 28 (01) :21-28
[5]   Does hyperinsulinemia preserve bone? [J].
BarrettConnor, E ;
KritzSilverstein, D .
DIABETES CARE, 1996, 19 (12) :1388-1392
[6]  
BARRETTCONNOR E, 1992, JAMA-J AM MED ASSOC, V268, P3333
[7]  
Bartos V, 2001, Cas Lek Cesk, V140, P299
[8]   Bone mineral in pre- and postmenopausal women with insulin-depdendent and non-insulin-dependent diabetes mellitus [J].
Christensen, JO ;
Svendsen, OL .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (04) :307-311
[9]   AMYLIN STIMULATES OSTEOBLAST PROLIFERATION AND INCREASES MINERALIZED BONE VOLUME IN ADULT MICE [J].
CORNISH, J ;
CALLON, KE ;
COOPER, GJS ;
REID, IR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 207 (01) :133-139
[10]  
El Miedany YM, 1999, CLIN EXP RHEUMATOL, V17, P561